Form 4: LifeStance Health Group Director, Teresa DeLuca, Acquires 35,211 Shares of Common Stock

Director Teresa DeLuca acquired 35,211 shares of LifeStance Health Group, Inc. common stock on August 14, 2024, bringing her total holdings to 71,574 shares.

Summary

• On August 14, 2024, Teresa DeLuca, a director of LifeStance Health Group, Inc., acquired 35,211 shares of common stock.
• The acquisition was made through the receipt of restricted stock units (RSUs), each representing a contingent right to receive one share of the Issuer's common stock.
• Following the transaction, DeLuca's total beneficial ownership of LifeStance Health Group, Inc. common stock is 71,574 shares.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing a stock transaction by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Positives

• The acquisition of shares by a director could be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC when a company insider, such as a director, engages in a transaction involving the company's securities. It provides transparency to the market regarding the trading activities of those with privileged access to company information.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as insider buying is often viewed favorably.

Key Dates